The CA 19-9 blood test measures a tumour marker associated with certain cancers. It is used to support monitoring and treatment assessment but is not intended to diagnose or screen for cancer.
1 biomarker as listed by Blue Horizon Medicals.
The CA 19-9 blood test measures the level of Cancer Antigen 19-9 (CA 19-9), a tumour marker that may be elevated in certain cancers and some non-cancerous conditions.
The CA 19-9 tumour marker blood test is not a diagnostic test or a general screening test for cancer. It is primarily used alongside other clinical investigations to monitor patients with a known condition, assess response to treatment, or check for changes over time.
A raised CA 19-9 result does not necessarily mean that cancer is present. Levels may also be increased by a range of benign conditions, including inflammation, gallstones, bile duct obstruction, pancreatitis and liver disease.
Results should always be interpreted by a doctor alongside your symptoms, medical history, imaging scans and any other relevant laboratory tests.
Description provided by Blue Horizon Medicals.
This test checks for HPV strains which increase cervical cancer risk. The test uses a self-collection vaginal swab kit with instructions on how to collect a sample at home.
A test that looks for bone cancer markers in your blood.
For women who concerned about their cervical health. This test detects anything that is not normal in your cervical cells.
